Baker D G, West S A, Orth D N, Hill K K, Nicholson W E, Ekhator N N, Bruce A B, Wortman M D, Keck P E, Geracioti T D
Psychiatry Service, Cincinnati Veterans Affairs Medical Center, OH 15220, USA.
Psychoneuroendocrinology. 1997 Oct;22(7):517-29. doi: 10.1016/s0306-4530(97)00053-x.
Opioid-mediated analgesia develops in experimental animals following traumatic stress and increased opioid-mediated analgesia has been observed in combat veterans with post-traumatic stress disorder (PTSD). These observations have led to the hypothesis that increased central nervous system (CNS) opioidergic activity exists in patients with PTSD. However, direct CNS data on opioid peptide concentrations and dynamics in patients with PTSD are lacking. We withdrew cerebrospinal fluid (CSF) via a flexible, indwelling subarachnoid catheter over a 6-h period and determined hourly CSF concentrations of immunoreactive beta-endorphin (ir beta END) in 10 well-characterized combat veterans with PTSD and nine matched normal volunteers. Blood was simultaneously withdrawn to obtain plasma for ir beta END. PTSD symptom clusters, as measured by the CAPS, were correlated with neuroendocrine data. Mean CSF ir beta END was significantly greater in patients with PTSD compared with normals and there was a negative correlation between the ir beta END and PTSD intrusive and avoidant symptoms of PTSD. No intergroup difference between plasma ir beta END was found, nor was there a significant correlation between CSF and plasma ir beta END. Immunoreactive beta-lipotropin (ir beta LPH) and pro-opiomelanocortin (irPOMC), both precursors of beta END, were much more plentiful in human CSF than was beta-endorphin itself, as has been previously reported. It remains to be determined whether the increased CNS opioid concentrations predate traumatic stress, thereby conferring a vulnerability to dissociative states and PTSD itself, or result from the trauma. The negative correlation between CSF ir beta END and avoidant and intrusive symptoms suggests that CNS hypersecretion of opioids might constitute an adaptive response to traumatic experience. Poor correlation between CSF and plasma ir beta END limits use of plasma measures to assess CNS opioid activity.
在实验动物遭受创伤应激后会产生阿片类药物介导的镇痛作用,并且在患有创伤后应激障碍(PTSD)的退伍军人中也观察到阿片类药物介导的镇痛作用增强。这些观察结果引发了这样一种假设,即PTSD患者存在中枢神经系统(CNS)阿片能活性增强。然而,目前缺乏关于PTSD患者阿片肽浓度和动态变化的直接中枢神经系统数据。我们通过一根柔软的留置蛛网膜下腔导管在6小时内抽取脑脊液(CSF),并测定了10名特征明确的患有PTSD的退伍军人和9名匹配的正常志愿者每小时脑脊液中免疫反应性β-内啡肽(irβEND)的浓度。同时抽取血液以获取血浆用于检测irβEND。通过CAPS测量的PTSD症状群与神经内分泌数据相关。与正常人相比,PTSD患者的脑脊液irβEND平均水平显著更高,并且irβEND与PTSD的侵入性和回避性症状之间存在负相关。未发现血浆irβEND在组间存在差异,脑脊液和血浆irβEND之间也没有显著相关性。正如先前报道的那样,β-内啡肽的两种前体免疫反应性β-促脂素(irβLPH)和阿片促黑皮质素原(irPOMC)在人脑脊液中的含量比β-内啡肽本身丰富得多。目前尚有待确定中枢神经系统阿片类药物浓度升高是在创伤应激之前就已存在,从而使人易患分离状态和PTSD本身,还是由创伤导致的。脑脊液irβEND与回避性和侵入性症状之间的负相关表明,中枢神经系统阿片类药物的过度分泌可能是对创伤经历的一种适应性反应。脑脊液和血浆irβEND之间的低相关性限制了使用血浆测量来评估中枢神经系统阿片类药物活性。